MRK:Merck & Co Inc Snapshot | Charting | News | Options
$143.93 NYSE 8:30a ET
September 10 '26 		Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
     GlobeNewswire
    Full Story →

    Headline News
    Health Canada Approves KEYTRUDA(EQNX::registered) for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after radical cystectomy as adjuvant treatment
    11:00a ET August 5 '26 CNW Group
    Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
    8:30a ET June 24 '26 GlobeNewswire
    The Quest to Repair What Multiple Sclerosis Takes Away
    8:30a ET June 24 '26 GlobeNewswire
    More News →
    Day  0.54%Week  4.26%Month  6.18%More Charting →
    September 11 '26. Markets Closed.
    Last $143.93
    Day change   0.54%$0.78
    Open $145.52
    Gap at open $0.81
    Previous close $144.71
    Trading volume 8,679,443
    10 Day avg vol. 8,488,577
    Shares out. 2.5Bil
    Market cap. $355.1Bil
    Trading activity Above Avg.
    Previous data from yesterday, September 10 '26.

    Historical Price Performance
    3 month   20.90% 
    6 month   24.69% 
    1 year   73.81% 
    2 year   24.89% 

    Earnings
    Previous 12m $1.25
    Next 12m Estimate $2.75
    P/E ratio 115.0x
    Revenue 66,569Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.